Mutual of America Capital Management LLC Sells 1,556 Shares of Maximus, Inc. (NYSE:MMS)

Mutual of America Capital Management LLC lessened its stake in shares of Maximus, Inc. (NYSE:MMSFree Report) by 4.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 34,809 shares of the health services provider’s stock after selling 1,556 shares during the period. Mutual of America Capital Management LLC owned 0.06% of Maximus worth $2,983,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Assenagon Asset Management S.A. boosted its position in shares of Maximus by 151.6% during the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after acquiring an additional 140,481 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Maximus during the first quarter worth about $2,601,000. Tidal Investments LLC raised its holdings in Maximus by 238.9% in the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock valued at $1,071,000 after buying an additional 8,997 shares during the last quarter. SG Americas Securities LLC increased its position in Maximus by 609.6% in the 2nd quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after acquiring an additional 12,266 shares during the period. Finally, Entropy Technologies LP acquired a new stake in Maximus in the first quarter valued at $491,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Trading Up 0.7 %

NYSE MMS opened at $90.57 on Tuesday. The firm has a market capitalization of $5.51 billion, a PE ratio of 23.77 and a beta of 0.76. The business’s 50-day moving average price is $89.82 and its two-hundred day moving average price is $86.18. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $93.97.

Maximus (NYSE:MMSGet Free Report) last announced its earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.47 by $0.27. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter last year, the firm earned $0.78 earnings per share. Maximus’s quarterly revenue was up 10.6% on a year-over-year basis. On average, analysts expect that Maximus, Inc. will post 6.12 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.32%. The ex-dividend date was Thursday, August 15th. Maximus’s dividend payout ratio (DPR) is presently 31.50%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.